Back to all studies
CompletedNCT01074294

Safety and Efficacy of OPC-34712 for ADHD

This study is completed in the United States. It is testing Safety and Efficacy of OPC-34712 for ADHD.

ADHDBehavioralFrom 18 Years to 55 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

This summary needs review. Please check the official study record and contact the research team for details.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: March 16, 2010
Recruitment status
Completed
Enrollment listed in the registry
740
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Behavioral
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT01074294
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adult Attention Deficit/ Hyperactivity Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01074294. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 35 sites
  • Little Rock
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Beverly Hills
    Beverly Hills, California
    Site status: Not listed — confirm with the team
  • Irvine
    Irvine, California
    Site status: Not listed — confirm with the team
  • Pasadena
    Pasadena, California
    Site status: Not listed — confirm with the team
  • San Francisco
    San Francisco, California
    Site status: Not listed — confirm with the team
  • Bradenton
    Bradenton, Florida
    Site status: Not listed — confirm with the team
  • Jacksonville
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Maitland
    Maitland, Florida
    Site status: Not listed — confirm with the team
  • North Miami
    North Miami, Florida
    Site status: Not listed — confirm with the team
  • Orlando
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • South Miami
    South Miami, Florida
    Site status: Not listed — confirm with the team
  • Atlanta
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Smyrna
    Smyrna, Georgia
    Site status: Not listed — confirm with the team
  • Indianapolis
    Indianapolis, Indiana
    Site status: Not listed — confirm with the team
  • Overland Park
    Overland Park, Kansas
    Site status: Not listed — confirm with the team
  • Rochester Hills
    Rochester Hills, Michigan
    Site status: Not listed — confirm with the team
  • Saint Charles
    Saint Charles, Missouri
    Site status: Not listed — confirm with the team
  • Cherry Hill
    Cherry Hill, New Jersey
    Site status: Not listed — confirm with the team
  • Willingboro
    Willingboro, New Jersey
    Site status: Not listed — confirm with the team
  • New York
    New York, New York
    Site status: Not listed — confirm with the team
  • Chapel Hill
    Chapel Hill, North Carolina
    Site status: Not listed — confirm with the team
  • Durham
    Durham, North Carolina
    Site status: Not listed — confirm with the team
  • Cincinnati
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Dayton
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • Oklahoma City
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Portland
    Portland, Oregon
    Site status: Not listed — confirm with the team
  • Philadelphia
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Memphis
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Austin
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Houston
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Salt Lake City
    Salt Lake City, Utah
    Site status: Not listed — confirm with the team
  • Woodstock
    Woodstock, Vermont
    Site status: Not listed — confirm with the team
  • Herndon
    Herndon, Virginia
    Site status: Not listed — confirm with the team
  • Bellevue
    Bellevue, Washington
    Site status: Not listed — confirm with the team
  • Seattle
    Seattle, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring psychotherapy or therapy for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving OPDC-34712, Placebo, Stimulant Therapy. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with adhd; age range: From 18 Years to 55 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.otsuka.co.jp/en/. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me